Andrew J. Muir and John G. McHutchison Growth factors during HCV therapy may be “cost-effective”, but are they “effective”? Hepatology 44
Article first published online: 28 NOV 2006 | DOI: 10.1002/hep.21426
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.